CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net income	$ 163,749,000	$ (4,698,000)
Adjustment to reconcile net income to net cash from operating activities:
Depreciation and amortization	15,343,000	13,691,000
Loss on warrant liability	0	1,073,000
Impairment of assets	0	3,899,000
Impairment of goodwill	0	3,197,000
Derecognition of goodwill	0	453,000
Stock-based compensation expense	119,606,000	1,952,000
Changes to deferred taxes	22,942,000	(1,743,000)
Debt accretion expense	756,000	805,000
Changes in operating assets and liabilities:
(Increase)/Decrease in Inventories	(308,000)	1,131,000
(Increase)/Decrease in Income tax receivable	(12,097,000)	0
(Increase)/Decrease in Prepaid expenses and other current assets	(6,376,000)	(1,361,000)
(Increase)/Decrease in Operating right-of-use assets	518,000	411,000
Increase/(Decrease) in Operating lease liabilities	(164,000)	(692,000)
Increase/(Decrease) in Accrued arbitration expenses	16,571,000	0
Increase/(Decrease) in Accrued income tax expense	(26,533,000)	0
Increase/(Decrease) in Accrued expenses and other current liabilities	2,527,000	16,698,000
Net cash provided by operating activities	177,736,000	23,099,000
Cash flows from investing activities:
Acquisitions of property and equipment	(1,117,000)	(1,909,000)
Proceeds from restricted short-term investment	2,941,000	0
Cash related to sale of business	0	(361,000)
Cash related to asset acquisition	(1,994,000)	0
Net cash used in investing activities	(170,000)	(2,270,000)
Cash flows from financing activities:
Proceeds from lines of credit	5,043,000	1,132,000
Proceeds from notes payable	273,000	7,015,000
Repayments of lines of credit	(3,293,000)	(1,119,000)
Repayments of notes payable	(8,319,000)	(8,332,000)
Repayments of finance leases	(4,004,000)	(1,924,000)
Proceeds from common stock issuance, net issuance costs	0	9,202,000
Proceeds from exercise of warrants	0	801,000
Members' contributions	316,000	961,000
Members' distributions	(42,174,000)	(3,659,000)
Net cash provided by (used in) financing activities	(52,158,000)	4,077,000
Net increase in cash and cash equivalents	125,408,000	24,906,000
Cash and cash equivalents - beginning of the period	40,640,000	22,002,000
Cash and cash equivalents - end of the period	166,048,000	46,908,000
Nonrelated Party
Changes in operating assets and liabilities:
(Increase)/Decrease in Accounts receivable	(154,960,000)	(4,253,000)
Increase/(Decrease) in Accounts payable	36,637,000	(7,975,000)
Related Party
Changes in operating assets and liabilities:
(Increase)/Decrease in Accounts receivable	(3,751,000)	550,000
Increase/(Decrease) in Accounts payable	$ 3,276,000	$ (39,000)